Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Hiroshi Mori,Hiroshi Wakabayashi,Shintaro Saito,Kenichi Nakajima,Kotaro Yoshida,Tomo Hiromasa,Seigo Kinuya
DOI: https://doi.org/10.1038/s41598-024-64607-2
IF: 4.6
2024-06-16
Scientific Reports
Abstract:This study aimed to compare tumor lesion detectability and diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) and radioiodine-labeled meta-iodo-benzylguanidine ( m IBG) imaging techniques in patients with metastatic pheochromocytoma and paraganglioma (PPGL). This retrospective study included 13 patients had pheochromocytoma and 5 had paraganglioma, who were all suspected of having metastatic tumors. Each patient underwent WB-MRI and 123 I- m IBG as a pretreatment screening for 131 I- m IBG therapy. Two expert reviewers evaluated WB-MRI, 123 I- m IBG images, and post-therapy 131 I- m IBG images for the presence of metastatic lesions in the lungs, bones, liver, lymph nodes, and other organs. Diagnostic measures for detecting metastatic lesions, including sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and receiver operating characteristics (ROC)—area under the curve (AUC), were calculated for each imaging technique. We analyzed WB-MRI images for detecting metastatic lesions, which demonstrated sensitivity, specificity, accuracy, PPV, NPV, and AUC of 82%, 97%, 90%, 96%, 86%, and 0.92, respectively. These values were 83%, 95%, 89%, 94%, 86%, and 0.90 in 123 I- m IBG images and 85%, 92%, 89%, 91%, 87%, and 0.91 in post-therapy 131 I- m IBG images, respectively. Our results reveal the comparable diagnostic accuracy of WB-MRI to one of the m IBG images.
multidisciplinary sciences